Monia BP - Search Results

1

Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.

Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, Wacheck V. Sieghart W, et al. Among authors: monia bp. J Hepatol. 2006 Jan;44(1):151-7. doi: 10.1016/j.jhep.2005.09.010. Epub 2005 Oct 25. J Hepatol. 2006. PMID: 16289418

2

Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells.

Wacheck V, Cejka D, Sieghart W, Losert D, Strommer S, Crevenna R, Monia BP, Selzer E. Wacheck V, et al. Among authors: monia bp. Cancer Biol Ther. 2006 Oct;5(10):1348-54. doi: 10.4161/cbt.5.10.3224. Epub 2006 Oct 26. Cancer Biol Ther. 2006. PMID: 16969094 Free article.

3

Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells.

Guensberg P, Wacheck V, Lucas T, Monia B, Pehamberger H, Eichler HG, Jansen B. Guensberg P, et al. Chemotherapy. 2002 Sep;48(4):189-95. doi: 10.1159/000063873. Chemotherapy. 2002. PMID: 12218266

4

Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy.

Heere-Ress E, Thallinger C, Lucas T, Schlagbauer-Wadl H, Wacheck V, Monia BP, Wolff K, Pehamberger H, Jansen B. Heere-Ress E, et al. Among authors: monia bp. Int J Cancer. 2002 May 1;99(1):29-34. doi: 10.1002/ijc.10248. Int J Cancer. 2002. PMID: 11948488

5

Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.

Thallinger C, Wolschek MF, Wacheck V, Maierhofer H, Günsberg P, Polterauer P, Pehamberger H, Monia BP, Selzer E, Wolff K, Jansen B. Thallinger C, et al. Among authors: monia bp. J Invest Dermatol. 2003 Jun;120(6):1081-6. doi: 10.1046/j.1523-1747.2003.12252.x. J Invest Dermatol. 2003. PMID: 12787138 Free article.

6

Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide.

Thallinger C, Wolschek MF, Maierhofer H, Skvara H, Pehamberger H, Monia BP, Jansen B, Wacheck V, Selzer E. Thallinger C, et al. Among authors: monia bp. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4185-91. doi: 10.1158/1078-0432.CCR-03-0774. Clin Cancer Res. 2004. PMID: 15217956

7

Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides.

Aichberger KJ, Mayerhofer M, Krauth MT, Skvara H, Florian S, Sonneck K, Akgul C, Derdak S, Pickl WF, Wacheck V, Selzer E, Monia BP, Moriggl R, Valent P, Sillaber C. Aichberger KJ, et al. Among authors: monia bp. Blood. 2005 Apr 15;105(8):3303-11. doi: 10.1182/blood-2004-02-0749. Epub 2004 Dec 30. Blood. 2005. PMID: 15626746 Free article.

8

Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death.

Skvara H, Thallinger C, Wacheck V, Monia BP, Pehamberger H, Jansen B, Selzer E. Skvara H, et al. Among authors: monia bp. Anticancer Res. 2005 Jul-Aug;25(4):2697-703. Anticancer Res. 2005. PMID: 16080514 Free article.

9

Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells.

Wacheck V, Selzer E, Günsberg P, Lucas T, Meyer H, Thallinger C, Monia BP, Jansen B. Wacheck V, et al. Among authors: monia bp. Br J Cancer. 2003 Oct 6;89(7):1352-7. doi: 10.1038/sj.bjc.6601254. Br J Cancer. 2003. PMID: 14520471 Free PMC article.

10

Antisense therapy for cancer.

Gleave ME, Monia BP. Gleave ME, et al. Among authors: monia bp. Nat Rev Cancer. 2005 Jun;5(6):468-79. doi: 10.1038/nrc1631. Nat Rev Cancer. 2005. PMID: 15905854 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters